UA37251C2 - Substance for treatment and prevention of viral hepatitis b and method for treating viral hepatitis b - Google Patents

Substance for treatment and prevention of viral hepatitis b and method for treating viral hepatitis b

Info

Publication number
UA37251C2
UA37251C2 UA93004171A UA93004171A UA37251C2 UA 37251 C2 UA37251 C2 UA 37251C2 UA 93004171 A UA93004171 A UA 93004171A UA 93004171 A UA93004171 A UA 93004171A UA 37251 C2 UA37251 C2 UA 37251C2
Authority
UA
Ukraine
Prior art keywords
viral hepatitis
prevention
substance
treatment
treating
Prior art date
Application number
UA93004171A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Філліп Аллен Фурман
Филлип Аллен Фурман
Джордж Роберт Пеінтер
Джордж Роберт Пейнтер
Original Assignee
Дзе Веллкам Фаундейшн Лімітед
Дзе Веллкам Фаундейшн Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Веллкам Фаундейшн Лімітед, Дзе Веллкам Фаундейшн Лимитед filed Critical Дзе Веллкам Фаундейшн Лімітед
Publication of UA37251C2 publication Critical patent/UA37251C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to the use of the derivatives of 1-(2-hydroxymethyl-1,3-oxathiolane-5-yl) cytosine and their physiologically active derivatives for treating viral hepatitis B.
UA93004171A 1991-05-02 1992-05-01 Substance for treatment and prevention of viral hepatitis b and method for treating viral hepatitis b UA37251C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919109506A GB9109506D0 (en) 1991-05-02 1991-05-02 Therapeutic nucleosides
PCT/GB1992/000803 WO1992019246A1 (en) 1991-05-02 1992-05-01 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection

Publications (1)

Publication Number Publication Date
UA37251C2 true UA37251C2 (en) 2001-05-15

Family

ID=10694346

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93004171A UA37251C2 (en) 1991-05-02 1992-05-01 Substance for treatment and prevention of viral hepatitis b and method for treating viral hepatitis b

Country Status (14)

Country Link
EP (1) EP0583274A1 (en)
JP (1) JPH06506929A (en)
AU (1) AU1662092A (en)
CA (1) CA2102120A1 (en)
GB (1) GB9109506D0 (en)
IE (1) IE921363A1 (en)
IL (1) IL101757A0 (en)
MX (1) MX9203214A (en)
MY (1) MY137298A (en)
PT (1) PT100435B (en)
RU (1) RU2104700C1 (en)
UA (1) UA37251C2 (en)
WO (1) WO1992019246A1 (en)
ZA (1) ZA923185B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US6175008B1 (en) 1988-04-11 2001-01-16 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923641B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
DK1140937T3 (en) 1998-12-23 2004-03-22 Shire Biochem Inc Antiviral nucleoside analogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5159067A (en) * 1987-01-28 1992-10-27 University Of Georgia Research Foundation Inc. 5'-Diphosphohexose nucleoside pharmaceutical compositions
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds

Also Published As

Publication number Publication date
RU2104700C1 (en) 1998-02-20
ZA923185B (en) 1993-11-01
GB9109506D0 (en) 1991-06-26
CA2102120A1 (en) 1992-11-03
WO1992019246A1 (en) 1992-11-12
IE921363A1 (en) 1992-11-04
PT100435A (en) 1993-09-30
PT100435B (en) 1999-08-31
EP0583274A1 (en) 1994-02-23
MY137298A (en) 2009-01-30
IL101757A0 (en) 1992-12-30
AU1662092A (en) 1992-12-21
JPH06506929A (en) 1994-08-04
MX9203214A (en) 1992-07-01

Similar Documents

Publication Publication Date Title
DE69232649D1 (en) USE OF 5-FLUORO-2'-DEOXY-3'-THIACYTIDINE FOR TREATING HEPATITIS B
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
MY121548A (en) Compounds and methods for the treatment of cancer
NO922949L (en) RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES
DE69830751D1 (en) Polyaromatic compounds for the treatment of herpes infections
DE69526937D1 (en) USE OF METHANBISPHOSPHONIC ACID DERIVATIVES FOR TREATING LOSSED PROSTHESES
ES2125976T3 (en) OTHER DERIVATIVES OF INDOL WITH ANTIVIRAL ACTION.
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
ATE303154T1 (en) USE OF A TRIFLURIDINE DERIVATIVE ALONE OR IN COMBINATION WITH A THYMIDINE PHOSPHORYLASE INHIBITOR FOR THE TREATMENT OF HIV
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
UA37251C2 (en) Substance for treatment and prevention of viral hepatitis b and method for treating viral hepatitis b
ZA991029B (en) Composition and methods for treatment of hiv infections.
AP9801286A0 (en) Therapeutic compounds.
DE69232417D1 (en) MICHELLAMINE FOR USE AS AN ANTIVIRAL ACTIVE SUBSTANCE, COMPOSITION AND TREATMENT METHOD
NO970573D0 (en) Yliden compounds and their preparation
MD960168A (en) Method for treatment of viral infections and compounds therefor
MY124071A (en) Treatment of viral disease in swine
ZA858237B (en) Ing 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamine method of medical treatment of human viral diseases utiliz
ATE204476T1 (en) USE OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZI E TO PRODUCE A MEDICATION FOR THE TREATMENT OF CERTAIN PAIN AND EDEMA
ES2014042A6 (en) Composition and method for treating hepatitis virus infections using 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil.
UA41338C2 (en) Method for inhibiting retroviral infection caused by human immunodeficiency virus (hiv), method for inhibiting human immunodeficiency virus (hiv)
ATE255417T1 (en) USE OF BRADYKININ ANTAGONISTS TO TREAT VIRUS DISEASES
AU630249B2 (en) Prevention of glycoprotein enveloped virus infectivity by quinolyloxazole-2-ones